EIF4E and cancer: Recent progress in molecular pathogenesis of cancer has identified eukaryotic translation initiation factor 4E (eIF4E), an oncogenic rate-limiting factor of cap-dependent translation to play a critical role in the translation of certain weak mRNAs such as cyclin D1, Bcl-2, MMPs and VEGF that are vital for oncogenic transformation [5–9].